NewAmsterdam Pharma Company N.V. (NAMS) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Source: SeekingAlpha
2025-12-03 18:33:25 ET
NewAmsterdam Pharma Company N.V. (NAMS) Citi Annual Global Healthcare Conference 2025 December 3, 2025 3:15 PM EST...
Read the full article on Seeking Alpha
For further details see:
NewAmsterdam Pharma Company N.V. (NAMS) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
NewAmsterdam Pharma Company N.V. Warrant
NASDAQ: NAMSW
NAMSW Trading
0.0% G/L:
$20.05 Last:
341 Volume:
$20.05 Open:
NAMSW Latest News
March 06, 2026 04:01:00 pm
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 18, 2026 07:00:00 am
NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provides Corporate Update
February 04, 2026 08:00:00 am
NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit
January 09, 2026 08:00:00 am
NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities
NAMSW Stock Data
$3,968,678,140
62,439,780
N/A
35
N/A
Biotechnology & Life Sciences
Healthcare
NL
Naarden
